SCHEMBL5964592

SCHEMBL5964592

Cc1cc(Oc2c(Br)cc(C(C)C(=O)O)cc2Br)ccc1O

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
THRA P10827 13/20 0.53
THRB P10828 13/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5861511 0.86 THRB (0.52) THRATHRB
SCHEMBL5964843 0.86 THRA (0.73) THRATHRB
SCHEMBL5964834 0.84 THRA (0.50) THRATHRB
SCHEMBL5964846 0.83 THRA (0.48) THRATHRB
SCHEMBL5858288 0.81 PTGS2 (0.54) THRATHRB
SCHEMBL5964537 0.80 THRA (0.62) THRATHRB
SCHEMBL5964531 0.79 THRA (0.52) THRATHRB
SCHEMBL5964560 0.78 THRA (0.44) THRATHRB
SCHEMBL5363051 0.76 THRB (0.58) THRATHRB
SCHEMBL5859459 0.76 THRA (0.43) THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7153997-B2 Benzamide derivatives as thyroid receptor ligands KARO BIO AB (SE) 2006-12-26 US disclosed
US-20060135614-A1 Novel compounds NORIN, THOMAS ANDERS WILSON (SE) 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135614-A1 Novel compounds THRB, TSHR, THRA THRA 3/4885THRB 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.